Gene transfer of apolipoprotein A-V improves the hypertriglyceridemic phenotype of apoa5 (-/-) mice.
about
Apolipoprotein A-V gene therapy for disease prevention / treatment:a critical analysisBiochemical and Physiological Improvement in a Mouse Model of Smith-Lemli-Opitz Syndrome (SLOS) Following Gene Transfer with AAV Vectors.Apolipoprotein A-V deficiency enhances chylomicron production in lymph fistula miceAAV-mediated gene therapy for atherosclerosis.Aberrant hetero-disulfide bond formation by the hypertriglyceridemia-associated p.Gly185Cys APOA5 variant (rs2075291).
P2860
Gene transfer of apolipoprotein A-V improves the hypertriglyceridemic phenotype of apoa5 (-/-) mice.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Gene transfer of apolipoprotei ...... phenotype of apoa5 (-/-) mice.
@en
type
label
Gene transfer of apolipoprotei ...... phenotype of apoa5 (-/-) mice.
@en
prefLabel
Gene transfer of apolipoprotei ...... phenotype of apoa5 (-/-) mice.
@en
P2093
P2860
P1476
Gene transfer of apolipoprotei ...... phenotype of apoa5 (-/-) mice.
@en
P2093
Gordon Watson
Jennifer A Beckstead
Jens B Simonsen
Lisa Nelbach
Trudy M Forte
Vineeta Sharma
P2860
P304
P356
10.1161/ATVBAHA.112.301078
P407
P577
2013-01-17T00:00:00Z